We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.69B
AUM Growth
+$56.3M
Cap. Flow
+$7.4M
Cap. Flow %
0.44%
Top 10 Hldgs %
18.14%
Holding
856
New
82
Increased
316
Reduced
389
Closed
59

Sector Composition

Rank Sector Weight
1 Healthcare 12.66%
2 Financials 9.78%
3 Technology 8.27%
4 Industrials 5.45%
5 Consumer Staples 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBWP icon
576
Invesco KBW Property & Casualty Insurance ETF
KBWP
$269M
$401K 0.02%
4,900
RAPT
577
DELISTED
RAPT Therapeutics
RAPT
$400K 0.02%
+2,676
New +$417K
CAC icon
578
Camden National
CAC
$973M
$396K 0.02%
12,798
-221
-2% -$7.07K
AMPH icon
579
Amphastar Pharmaceuticals
AMPH
$867M
$395K 0.02%
6,878
-104
-1% -$4.61K
FWRD icon
580
Forward Air
FWRD
$646M
$393K 0.02%
3,708
-190
-5% -$19.4K
MUR icon
581
Murphy Oil
MUR
$5.07B
$393K 0.02%
10,272
-423
-4% -$15.6K
MGRC icon
582
McGrath RentCorp
MGRC
$2.97B
$391K 0.02%
4,225
-221
-5% -$20.2K
NAVI icon
583
Navient
NAVI
$818M
$390K 0.02%
20,985
-1,933
-8% -$31.8K
ADC icon
584
Agree Realty
ADC
$9.14B
$389K 0.02%
5,952
-80
-1% -$5.29K
EA
585
DELISTED
Electronic Arts
EA
$389K 0.02%
2,996
+85
+3% +$10.8K
INCY icon
586
Incyte
INCY
$24.4B
$389K 0.02%
6,246
+1,168
+23% +$78.1K
OMCL icon
587
Omnicell
OMCL
$1.68B
$388K 0.02%
5,262
+564
+12% +$38K
RNAM
588
DELISTED
Avidity Biosciences
RNAM
$388K 0.02%
+34,943
New +$438K
MZTI
589
The Marzetti Company
MZTI
$3.18B
$387K 0.02%
1,925
-73
-4% -$14.8K
MSD
590
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
$384K 0.02%
59,664
-57,057
-49% -$371K
QCOM icon
591
Qualcomm
QCOM
$172B
$384K 0.02%
3,227
+647
+25% +$74.4K
VTWO icon
592
Vanguard Russell 2000 ETF
VTWO
$17.3B
$384K 0.02%
5,084
-3,249
-39% -$234K
CALM icon
593
Cal-Maine
CALM
$3.9B
$381K 0.02%
8,458
-350
-4% -$17.4K
MRNA icon
594
Moderna
MRNA
$23.9B
$380K 0.02%
3,125
+574
+23% +$76.6K
INBX
595
DELISTED
Inhibrx, Inc. Common Stock
INBX
$380K 0.02%
+14,633
New +$342K
NTAP icon
596
NetApp
NTAP
$39.1B
$371K 0.02%
4,859
-324
-6% -$21.9K
AGCO icon
597
AGCO
AGCO
$7.18B
$370K 0.02%
2,815
+396
+16% +$49.1K
ALSN icon
598
Allison Transmission
ALSN
$10.5B
$367K 0.02%
6,497
-7,938
-55% -$391K
SSD icon
599
Simpson Manufacturing
SSD
$8.12B
$367K 0.02%
2,651
-28
-1% -$3.44K
PRK icon
600
Park National Corp
PRK
$3.65B
$365K 0.02%
3,569
-48
-1% -$5.1K

Similar funds

Hennion & Walsh Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Hennion & Walsh Asset Management held 856 positions worth $1.69B, up 3.5% from $1.63B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management's Q2 2023 filing shows 82 new, 316 increased, 389 reduced and 59 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 834,517 shares worth $37M. The largest sale was Vanguard Morningstar Value ETF, an estimated $19.1M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q2 2023 buy was JPMorgan US Quality Factor ETF: 834,517 shares worth $37M.
  • Hennion & Walsh Asset Management added most to WisdomTree International Quality Dividend Growth Fund in Q2 2023, an estimated $19.5M increase.
  • Hennion & Walsh Asset Management's biggest Q2 2023 reduction was Vanguard Morningstar Value ETF, cutting an estimated $19.1M.
  • Hennion & Walsh Asset Management fully exited iShares MSCI USA Quality Factor ETF in Q2 2023, selling an estimated $15.4M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.69B portfolio in Q2 2023.
  • Hennion & Walsh Asset Management opened 82 new positions and closed 59 in Q2 2023.
  • Hennion & Walsh Asset Management's portfolio value rose 3.5% quarter-over-quarter to $1.69B.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.